Clinical trial

A Comparative Study Between Foraseq and Formoterol/Budesonide Inhalation Capsules in Patients with Asthma

NCT01001364

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-02-01

PhasePHASE3

Study timeline

Study start (unknown)2010-02-01Date precision: month

Registry last updated2025-03-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

ASTHMAunresolved

Interventions

Formoterol/BudesonideDRUG

ForaseqDRUG

Sponsors & collaborators

Eurofarma Laboratorios S.A.lead sponsor

Mapped research locations

São PauloSão Paulo, Brazil1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01001364 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.